CYCLIC INTRAVENOUS PAMIDRONATE THERAPY FOR OSTEOGENESIS IMPERFECTA TYPE IV.

David O. Sillence1, Julie Briody2, Jill Hall2, Jenny Ault3, Robert B. Howman-Giles4, Christopher T. Cowell5, Michael J. Hooper6,
Departments of 1Paediatrics and Child Health, 2Clinical Genetics, 3Rehabilitation, 4Nuclear Medicine and 5Endocrinology, New Children’s Hospital, Westmead, and 6Department of Endocrinology, Concord Repatriation General Hospital, Concord, Australia.